Reynders McVeigh Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.23M | Buy |
9,182
+25
| +0.3% | +$8.91K | 0.16% | 64 |
|
|
2025
Q4 | $3M | Buy |
9,157
+266
| +3% | +$84.4K | 0.14% | 66 |
|
|
2025
Q3 | $2.51M | Sell |
8,891
-158
| -2% | -$45.8K | 0.12% | 71 |
|
|
2025
Q2 | $2.53M | Sell |
9,049
-345
| -4% | -$97.7K | 0.13% | 71 |
|
|
2025
Q1 | $2.93M | Sell |
9,394
-46
| -0.5% | -$13.6K | 0.16% | 69 |
|
|
2024
Q4 | $2.46M | Sell |
9,440
-15
| -0.2% | -$4.45K | 0.13% | 72 |
|
|
2024
Q3 | $3.05M | Buy |
9,455
+402
| +4% | +$131K | 0.16% | 69 |
|
|
2024
Q2 | $2.83M | Buy |
9,053
+89
| +1% | +$26.1K | 0.16% | 68 |
|
|
2024
Q1 | $2.55M | Sell |
8,964
-110
| -1% | -$32.2K | 0.15% | 70 |
|
|
2023
Q4 | $2.61M | Sell |
9,074
-59
| -0.6% | -$16.1K | 0.17% | 69 |
|
|
2023
Q3 | $2.45M | Buy |
9,133
+816
| +10% | +$204K | 0.17% | 68 |
|
|
2023
Q2 | $1.85M | Buy |
8,317
+833
| +11% | +$193K | 0.12% | 76 |
|
|
2023
Q1 | $1.81M | Buy |
7,484
+148
| +2% | +$36.3K | 0.12% | 73 |
|
|
2022
Q4 | $1.93M | Sell |
7,336
-44
| -0.6% | -$11.8K | 0.14% | 73 |
|
|
2022
Q3 | $1.66M | Buy |
7,380
+42
| +0.6% | +$10.2K | 0.13% | 74 |
|
|
2022
Q2 | $1.78M | Buy |
7,338
+2
| +0% | +$490 | 0.13% | 73 |
|
|
2022
Q1 | $1.77M | Sell |
7,336
-35
| -0.5% | -$8.04K | 0.11% | 80 |
|
|
2021
Q4 | $1.66M | Sell |
7,371
-80
| -1% | -$16.9K | 0.09% | 87 |
|
|
2021
Q3 | $1.58M | Sell |
7,451
-273
| -4% | -$62.8K | 0.1% | 90 |
|
|
2021
Q2 | $1.88M | Sell |
7,724
-305
| -4% | -$75K | 0.12% | 83 |
|
|
2021
Q1 | $2M | Buy |
8,029
+81
| +1% | +$19.3K | 0.13% | 81 |
|
|
2020
Q4 | $1.83M | Sell |
7,948
-383
| -5% | -$88.3K | 0.12% | 77 |
|
|
2020
Q3 | $2.12M | Sell |
8,331
-60
| -0.7% | -$14.9K | 0.16% | 66 |
|
|
2020
Q2 | $1.98M | Buy |
8,391
+451
| +6% | +$103K | 0.17% | 67 |
|
|
2020
Q1 | $1.61M | Sell |
7,940
-87
| -1% | -$19K | 0.18% | 69 |
|
|
2019
Q4 | $1.94M | Buy |
8,027
+141
| +2% | +$31.1K | 0.19% | 75 |
|
|
2019
Q3 | $1.53M | Sell |
7,886
-628
| -7% | -$121K | 0.16% | 82 |
|
|
2019
Q2 | $1.57M | Sell |
8,514
-77
| -0.9% | -$13.8K | 0.17% | 81 |
|
|
2019
Q1 | $1.63M | Sell |
8,591
-929
| -10% | -$177K | 0.18% | 75 |
|
|
2018
Q4 | $1.85M | Sell |
9,520
-465
| -5% | -$90.7K | 0.25% | 69 |
|
|
2018
Q3 | $2.07M | Sell |
9,985
-202
| -2% | -$39.8K | 0.24% | 71 |
|
|
2018
Q2 | $1.88M | Sell |
10,187
-181
| -2% | -$32K | 0.24% | 71 |
|
|
2018
Q1 | $1.77M | Buy |
10,368
+64
| +0.6% | +$11.7K | 0.22% | 72 |
|
|
2017
Q4 | $1.79M | Hold |
10,304
| – | – | 0.23% | 68 |
|
|
2017
Q3 | $1.92M | Sell |
10,304
-25
| -0.2% | -$4.43K | 0.25% | 66 |
|
|
2017
Q2 | $1.78M | Sell |
10,329
-397
| -4% | -$64.6K | 0.24% | 70 |
|
|
2017
Q1 | $1.76M | Sell |
10,726
-131
| -1% | -$21.8K | 0.24% | 75 |
|
|
2016
Q4 | $1.59M | Hold |
10,857
| – | – | 0.23% | 80 |
|
|
2016
Q3 | $1.81M | Buy |
10,857
+75
| +0.7% | +$12.7K | 0.26% | 69 |
|
|
2016
Q2 | $1.64M | Sell |
10,782
-260
| -2% | -$40.4K | 0.24% | 78 |
|
|
2016
Q1 | $1.66M | Buy |
11,042
+871
| +9% | +$129K | 0.25% | 75 |
|
|
2015
Q4 | $1.65M | Buy |
10,171
+892
| +10% | +$140K | 0.27% | 64 |
|
|
2015
Q3 | $1.28M | Buy |
9,279
+700
| +8% | +$110K | 0.22% | 76 |
|
|
2015
Q2 | $1.32M | Buy |
8,579
+2,529
| +42% | +$405K | 0.22% | 77 |
|
|
2015
Q1 | $967K | Buy |
6,050
+600
| +11% | +$94.5K | 0.17% | 85 |
|
|
2014
Q4 | $868K | Hold |
5,450
| – | – | 0.15% | 90 |
|
|
2014
Q3 | $766K | Hold |
5,450
| – | – | 0.15% | 90 |
|
|
2014
Q2 | $645K | Sell |
5,450
-2,200
| -29% | -$255K | 0.15% | 104 |
|
|
2014
Q1 | $944K | Hold |
7,650
| – | – | 0.22% | 78 |
|
|
2013
Q4 | $873K | Hold |
7,650
| – | – | 0.22% | 79 |
|
|
2013
Q3 | $856K | Buy |
7,650
+220
| +3% | +$23.9K | 0.24% | 76 |
|
|
2013
Q2 | $733K | Buy |
+7,430
| New | +$771K | 0.22% | 79 |
|
Other funds holding AMGN
VCM
VPM
Reynders McVeigh Capital Management's AMGN Position: Q1 2026 in Review
Reynders McVeigh Capital Management increased its Amgen (AMGN) stake by 0.27% in Q1 2026, buying an estimated $8.91K and bringing the position to 9,182 shares worth $3.23M. The position accounts for 0.16% of the portfolio, ranked #64.
Reynders McVeigh Capital Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Reynders McVeigh Capital Management held 9,182 shares of Amgen worth $3.23M as of Q1 2026.
- Reynders McVeigh Capital Management bought 25 Amgen shares in Q1 2026, an estimated $8.91K.
- Amgen made up 0.16% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #64 holding.
- Reynders McVeigh Capital Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.